Clinical Trial Update: Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update describing a Phase 2/Phase 3 study of Tripterygium glycoside for inducing remission in Crohn's disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Tripterygium glycoside (Tripterygium glycoside)

Snippet

Sponsor: Zhu Weiming | Conditions: Inflammatory Bowel Diseases, Crohn's Disease | Phase 2, Phase 3 | Status: UNKNOWN